Tekatli

Postdoc - medical

Contact

Organs at risk proximity in central lung stereotactic ablative radiotherapy Nicolas Giraud, Hilâl Tekatli, Famke L. Schneiders, John R. van Sornsen de Koste, Marco Marzo, Miguel A. Palacios, Suresh Senan
Physics and Imaging in Radiation Oncology, 2025, vol. 34

Artificial intelligence-assisted quantitative CT analysis of airway changes following SABR for central lung tumors Hilâl Tekatli, Omar Bohoudi, Nicholas Hardcastle, Miguel A Palacios, Famke L Schneiders, Anna M E Bruynzeel, Shankar Siva, Suresh Senan
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2024, vol. 198

Ten years outcomes after SABR in central and ultracentral primary lung tumors Hilâl Tekatli, Nicolas Giraud, Rik van Eekelen, Frank J Lagerwaard, Suresh Senan
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2023, vol. 188, p.109848

The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma M. Duijm, E. Oomen-de Hoop, N. van Voort van der Zyp, P. van de Vaart, H. Tekatli, M. Hoogeman, S. Senan, J. Nuyttens
Radiotherapy and Oncology, 2021, vol. 156, p.223-230

Knowledge-Based Planning for Identifying High-Risk Stereotactic Ablative Radiation Therapy Treatment Plans for Lung Tumors Larger Than 5 cm Saar van t. Hof, Alexander R. Delaney, Hilâl Tekatli, Jos Twisk, Ben J. Slotman, Suresh Senan, Max Dahele, Wilko F.A.R. Verbakel
International Journal of Radiation Oncology Biology Physics, 2019, vol. 103, p.259-267

Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors H Tekatli, F O B Spoelstra, M Palacios, J van Sornsen de Koste, B J Slotman, S Senan
Lung Cancer, 2018, vol. 123, p.142-148